REGN2222 (SAR438584)

SAR438584 · Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN2222 (SAR438584), covering 2015-03-11 to 2015-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety and Tolerability of REGN2222(SAR438584) in Healthy Adult Volunteers [Phase 1]